Patent Grant
12158475
The present technology provides systems, apparatuses and associated methods to achieve spray deposition of biological samples. In particular, provided herein are automated specimen deposition systems capable of providing biological tissue/cellular deposition on microscopic slides for tissue sample analysis and for clinical, diagnostic, and research applications thereof.
Biological tissue samples are collected from patients for microscopic and molecular diagnostic analysis for clinical, diagnostic and research applications. These samples are collected in a variety of laboratory, medical clinic and other health-care or medical research settings. For example, cells/tissue can be collected from a patient using a collection device, such as a brush, swab or cutting tool for biopsies and placed into liquid in a sample container. When ready to prepare microscopic slides for screening and/or diagnosis, the sample liquid is drawn by vacuum through a filter. A microscope slide is pressed against the filter to transfer cells onto the slide for viewing and analysis. Alternatively, the sample liquid may be transferred from the sample vial to a glass slide via a pipettor or other suction-type device. Other, non-liquid-based approaches for viewing cells under microscope include directly smearing cells or tissues onto the surface of the slide with the collection device.
Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on illustrating clearly the principles of the present disclosure. Furthermore, components can be shown as transparent in certain views for clarity of illustration only and not to indicate that the illustrated component is necessarily transparent. For ease of reference, throughout this disclosure identical reference numbers may be used to identify identical or at least generally similar, analogous and/or complementary components or features.
The present technology is directed to apparatuses, systems, and methods for collecting biological specimens and for generating specimen-bearing substrates. For example, certain embodiments achieve spray deposition of biological specimens on substrates for microscopy and other suitable molecular and imaging modalities of investigation. In particular, provided herein are automated specimen deposition systems capable of providing biological specimen (e.g., tissue, cells) deposition on slide substrates for specimen analysis and for clinical, diagnostic, and research applications thereof. Other embodiments provide for collection, maintenance, transport and/or deposition of biological specimens in a manner that facilitates preservation of cellular structural integrity of the specimens for generating high-quality, low-variability specimen-bearing substrates.
Conventional systems and techniques for preparing biological samples on slides have inherent limitations relating to the quality of the biological sample. For example, the slides prepared using the standard manual and/or current automated techniques discussed above, can be highly variable and present screening and diagnosis challenges that, in some instances, require obtaining additional samples from the patient.
Several embodiments of the present technology provide high-quality and low-variability specimen-bearing substrates (e.g., microscope slides) that can be utilized for generating efficacious measurements for clinical and research applications. For example, biological specimens can be deposited on substrates in a manner that preserves and presents natural cell molecular and structural characteristics for imaging and other analysis. These specimen-bearing substrates demonstrate high quality, undamaged, monolayers of isolated cells to provide consistent and accurate measurements and diagnostic outcomes. Embodiments disclosed herein further provide for automation of one or more aspects of achieving high-quality specimen-bearing substrates in a manner that requires minimal technician assistance, thereby limiting quality variability and increasing diagnostic reliability. In certain embodiments, an automated specimen deposition process for achieving high-quality specimen-bearing substrates can be optimized for specific cell types, cell concentration and/or liquid-based preservation solution.
Specific details of several embodiments of the technology are described below with reference to
As used herein, the term “automated” refers to a method (e.g., “automated process”) in which one or more steps are performed without the need for operator intervention, or to a system or apparatus (e.g., “automated instrument”) that performs one or more of its functions without operator intervention.
As used herein, the term “fully automated” refers to a system, apparatus, or method that includes the capability of not requiring an operator for steps following initial set-up, yet is capable of maintaining the quality of the system performance over a time period unmonitored or unattended by an operator. In particular embodiments, an operator provides a sample to a system or apparatus and/or initiates acquisition, and samples and/or analysis is generated without subsequent operator intervention.
Systems, devices and methods are provided herein for generating reproducible high-quality specimen-bearing substrates. In some embodiments, methods and systems are presented for automation of specimen deposition of clinical or research-obtained biological samples on substrates, such as microscope slides for obtaining cell/tissue images and/or other clinical or research data associated with the biological samples. In one embodiment, a specimen deposition system for depositing biological material onto one or more substrates includes a substrate processing area for receiving and holding one or more substrates. The system can also include a spray cartridge configured to orient and direct a spray of biological material from a specimen container towards a surface of a substrate, and a positioning assembly having one or more alignment assemblies configured to align the spray cartridge with respect to the surface of the substrate.
The present technology is also directed to automated specimen deposition systems for depositing a biological specimen onto one or more substrates. In one embodiment, an automated specimen deposition system can include a positioning assembly configured to align a specimen-containing spray cartridge with respect to a surface of a substrate. The system can also include a substrate loading station for sequentially receiving and carrying substrates and a controller communicatively coupled to the positioning assembly. In certain embodiments, the controller is programed to (a) command the positioning assembly to position and align the spray cartridge above the substrate loading station, and (b) command a compressed air source to direct compressed air into the spray cartridge in a manner that sprays the specimen from a nozzle on the spray cartridge towards a substrate carried by the substrate loading station.
Other aspects of the present technology are directed to methods of depositing biological specimens on substrates. In one embodiment the method can include delivering a plurality of containers holding biological specimens to a carrier assembly within an automated specimen deposition system. The method can also include moving the carrier assembly towards a positioning assembly of the deposition system and sequentially moving the containers from the carrier assembly to the positioning assembly. The method can further include moving the positioning assembly from a receive container configuration to an align container configuration to move the individual containers at the positioning assembly to an aligned position above a substrate processing area. The method can also include transporting individual substrates to the substrate processing area and spraying the biological specimen onto an upper surface of an individual substrate to generate a specimen-bearing substrate.
Further aspects of the present technology are directed to methods for collecting specimens for use in a specimen deposition system. In one embodiment, a method can include collecting biological material from a subject, and depositing the biological material in a transport solution carried by a container. In certain embodiments, the transport solution comprises between about 10% and about 95% ethanol. In various arrangements, the biological material collected from the subject can be suitable for generating specimen-bearing microscope slides for partial wave spectrometry analysis.
The system 100 can automatically generate specimen-bearing substrates (e.g., slides) suitable for further processing. For example, specimen-bearing substrates generated using the technology disclosed herein are suitable for preparing specimens for microscopy, mass spectrometric methods, visual inspection, fluorescent visualization, microanalyses, imaging (e.g., digital imaging), or other analytical or imaging methods. For example, specimen-bearing substrates can undergo further processing including staining (e.g., H & E staining), antigen retrieval, or other types of protocols (e.g., immunohistochemistry, in situ hybridization, etc.). In some embodiments, the specimen-bearing substrates generated in accordance with the present technology are suitable for use for acquisition of partial wave spectroscopic (PWS) microscopic images and clinical, diagnostic, and research applications thereof. Examples of PWS apparatuses, systems, and methods of use thereof are described, for example, in U.S. Pat. Nos. 7,667,832; 7,800,746; 7,652,772; 8,131,348; U.S. Pat. App. Pub. No. 2012/0214880; U.S. Pat. App. Pub. No. 2008/0278713; U.S. Pat. App. Pub. No. 2008/0180664; and U.S. Pat. App. Pub. No. 2006/0155178; herein incorporated by reference in their entireties.
In various embodiments, the liquid (e.g., transport solution) can comprise ethanol (i.e., EtOH) or other liquid to preserve cell morphology and/or inhibit bacterial growth within the specimen container 200. In some embodiments, the liquid can comprise about 10% EtOH to about 95% EtOH, about 10% EtOH to about 90% EtOH, about 10% EtOH to about 85% EtOH, about 20% EtOH to about 70% EtOH, greater than about 10% EtOH, greater than about 20% EtOH, less than about 60% EtOH, about 20% EtOH, about 25% EtOH, about 30% EtOH, about 35% EtOH, about 40% EtOH, about 45% EtOH, or about 50% EtOH in deionized water. Other dilutions and/or liquids are also contemplated for use with specimen container 200.
Referring back to
In operation, a technician or other user can remove the upper cap 212 and penetrable upper septum, if necessary, and place liquids (e.g., transport solution) into the vessel 210. A biological specimen (e.g., a tissue biopsy, cell/tissue swab, cell/tissue scraping, etc.) can be deposited inside the vessel by dipping the collection device in the liquid such that the biological specimen is immersed and dispensed into the liquid. The penetrable upper septum and upper cap 212 can be sealed and/or secured on the upper portion of the vessel 210 and the specimen container 200 can be transported, for example, to the system 100. In some instances, the lower cap 216 can be removed in preparation for processing (e.g., deposition on a substrate). Following removal of the lower cap 214, the filled specimen container 200 can be received within the internal environment 101 and by the spray positioning assembly 140 (
In some embodiments, all or portions of the specimen container 200 are disposable. In some instances, disposable can refer to all or certain components of the specimen container 200 being suitable for single-time use. In other embodiments, the specimen container 200 can be reused or used more than once (e.g., following cleaning and/or sterilization). In certain instances, portions of the specimen container 200 may not be disposable (e.g., the vessel 210, the caps 212, 216) while other portions are disposable and/or need to be replaced (e.g., penetrable upper and lower septums). The specimen container 200 can be made from a variety of materials such as plastics, metals, rubber, silicon, etc. The specimen containers 200 can further include, without limitation, one or more human-readable or machine readable label (e.g., a barcode that can be read and/or recorded by the system 100).
In various embodiments, the housing 110 inhibits, limits, or substantially prevents contaminants from entering the internal processing environment 101. Referring to
In some embodiments, the upper housing 154 has a spray retainer 156 that provides a protective chamber for containing the spray of biological material during the spray deposition process. The spray retainer 156 is provided with an upper opening 157 for receiving therein a lower portion of the spray cartridge 120 (e.g., to accommodate the spray nozzle 126 of the spray cartridge 120) such that the spray nozzle 126 is aligned over the surface of substrate 151 selected for specimen deposition. As illustrated in
As shown in
In some embodiments, the system 100 can provide mechanisms for reducing the drying time of deposited liquid including, but not limited to, heating of surrounding air, heating of sample substrate, laminar flow of dry air over the wet substrate, etc. In additional embodiments, the system 100 can include sensors (e.g. optical) to monitor the drying of the wet substrate. Other embodiments can also include means to increase the quantity of cellular and/or tissue material on a sample slide through iterative deposition cycles with drying cycles between each deposition cycle. Such drying cycles can be performed with or without the various drying mechanisms discussed herein.
In some embodiments, the system 100 comprises automated hardware for fast and/or fully automated substrate processing such as spray deposition of biological material on substrates. In particular, the system 100 can include electronic stages, platforms and transport carriers for automated generation of specimen-bearing substrates.
As shown in
In some embodiments, the platform 132 can be securely positioned within the internal environment of the system 100 (e.g., anchored). In another embodiment, the platform 132 can be a moving platform that can be moved as an X-Y-Z transport system to facilitate both linear and vertical transport of carried substrates to/from various portions of the internal environment 101. For example, the substrate processing area 130 can include a motion system or actuator (not shown) that allows for movement of a substrate 151 (or substrate cartridge 150) relative to the other components (e.g., spray positioning assembly 140) of the system 100, the spray positioning assembly of the system relative to the substrate, or a combination thereof. In particular embodiments, a motion system can provide movement along the x-axis, y-axis, and/or z-axis, such that the loading station 134 can operatively move about a predetermined set of positions. In some embodiments, a motion system includes the loading station 134 that provides translational movement along a single axis (e.g., x-axis, y-axis, z-axis), for example by joining the loading station 134 to the platform 132 via a guide or linear bearing, such that the movement of the loading station 134 with respect to the platform 132 is restricted to translational motion along a single axis (e.g., x, y, z). In other embodiments, movement of the loading station 134 with respect to the platform 132 can occur along multiple or all axis (e.g., x-axis, y-axis, z-axis). In some embodiments, a guide allows movement via any suitable mechanism including, but not limited to, ball bearings, recirculating ball bearings, crossed roller ball, flexure, cylindrical sleeve, dovetail, etc. In some embodiments, movement along the guide is supplied by a linear actuator (e.g., motorize, pneumatic, hydraulic, Piezo, etc.).
Automation and/or high-throughput of the delivery of substrate cartridges 150 to and/or from the loading station 134 can be facilitated by linear guide carriages, linear motion actuator systems (not shown), motors (e.g., drive motors, stepper motors, etc.), drive elements (e.g., chains, belts, etc.), or other features for providing motion in the system 100 for transporting components such as substrates 151 and specimen containers 200 within the internal environment 101. Following spray deposition of the biological material onto one or more substrates, a user can remove the substrate cartridge(s) 150 from the loading station 134 or other holding/processing station within the internal environment 101 via the access door 114.
Referring again to
In various arrangements, the alignment assemblies 142 can further be coupled to one or more drive mechanisms 146 to visually, mechanically, electro-mechanically, and/or opto-mechanically manipulate and deliver the specimen containers 200 and align the spray cartridge 120 with the substrate processing area 130. For example, a drive mechanism 146 (e.g., an actuator assembly) can be operatively coupled to one or more motors suitable for mixing, shaking or vortexing a specimen container 200 to mix the cell suspension within the vessel 210. The drive mechanism 146 can also be operatively coupled to and/or driven by one or more motors (e.g., stepper motor, servo motor, etc.) for (a) moving the specimen container 200 within the enclosure 122 of the spray cartridge 120 and toward the spray nozzle 126, and (b) providing force to facilitate penetration of the penetrable lower septum of the specimen container 200 by the puncture mechanism 128 (
In some embodiments, the drive mechanism 146 can further include one or more positioners (not shown) or other visually (including optically) identifiable feature for convenient identification and orientation of the alignment assembly 142 with respect to the substrate processing area 130. For example, pre-determined positions known by the controller (not shown) can be used to identify a misalignment between the spray nozzle 126 of the spray cartridge 120 and the receiving substrate, and a user can be immediately notified that the alignment assembly 142 is misaligned. In some embodiments, the spray positioning assembly 140 can sequentially receive specimen containers 200 from a carrier assembly holding a plurality of specimen containers. In some embodiments, the spray positioning assembly 140 can be moved from a receive container configuration to an align container configuration. For example, the spray positioning assembly 140, following the transition of a specimen container 200 from the carrier assembly to the mounting mechanism 144 of the spray positioning assembly, move and align the specimen container, there is room. In one embodiment, the spray positioning assembly 140 is configured to carry one or more spray cartridges 120. In certain embodiments, a row of alignment assemblies (not shown) can independently mix and spray biological material from specimen containers onto substrates held in the substrate processing area 130. In other embodiments, the substrate processing area 130 and/or the spray positioning assembly 140 can include, without limitation, one or more sensors, readers, heaters, dryers, or other components that facilitate specimen deposition and/or processing of specimen-bearing substrates. In some embodiments, the substrate processing area 130 can include a pressure sensor (not shown) or other sensor for detecting the presence of a substrate cartridge 150 on the loading station 134.
In some embodiments, software, code, or other executable instructions are provided to direct and/or control (e.g., along with a controller or processor) automated specimen deposition by the system 100. In some embodiments, automation and/or high-throughput software is incorporated into the system 100, and provides one or more of: specimen intake, spray deposition, specimen switching, substrate indexing, other specimen-bearing substrate processing, etc.
In some embodiments, one or more of the components of a specimen deposition system 100 are under the control of one or more electronic controllers or computer processors. In certain embodiments, components and processes that enhance specimen deposition and enable automation and/or high-throughput capacity are controlled by a processor. In some embodiments, a processor controls numerous components of a specimen deposition system 100 and coordinates their actions to achieve the desired/directed function. For example, in some embodiments, movement of one or more (e.g., all) of the drive mechanisms and/or motors is automated. In other embodiments, movement is controlled and/or directed by a processor within or in communication with the system 100. In some embodiments, movement is synchronized with other actions of the system 100. In some embodiments, coupling and/or synchronization of steps enhances the automation and speed of the process of obtaining high-quality specimen-bearing substrates.
The system 2600 uses cartridges, optionally as illustrated in
The nozzle component 2801, illustrated in
The secondary nozzle 2806 may comprise various angles of opening to allow for different spray patterns. The position of the secondary nozzle 2806 with respect to the nozzle component 2801 may be varied to change the concentric pressure profile. The nozzle component 2801 joined with the secondary nozzle 2806 may comprise a seal 2807 (e.g. o-ring) at the junction to prevent vapor from escaping during use. The nozzle component 2801 may comprise a snap-in feature 2808 that locks the assembly into a slide cartridge chamber (not shown). The nozzle component 2801 may also have a guide 2809 that helps orient the nozzle component 2801 into a substrate cartridge (not shown). In one embodiment, a sample container screws directly onto the nozzle component with threads 2810. The nozzle assembly 2800 joined with a sample container 2701, can be placed into a designated area of a substrate cartridge 2705 and held into place using one or more snap fittings 2706.
A cartridge assembly 2700 comprising a sample container 2701, nozzle assembly 2800, substrate cartridge 2705, sample substrate 2708, and substrate holder 2709 can be inserted into portable specimen system 2600 by opening the door 2604 into the spray chamber. The system 2600 may comprise a base on which the cartridge 2602 may be placed. Then, the cartridge 2602 is either pushed in until it the gas port 2802 mates with a gas source (not shown) or the act of closing the door pushes the cartridge in until the gas port 2802 mates with a gas source (not shown), and the cartridge 2602 is locked into place. In one embodiment, the gas port 2802 of the nozzle component 2801 will mate with a gas source (not shown) inside the system 2600. The system is activated from the user interface which may be a touch screen 2603 or panel with buttons (not shown) or a computer workstation (not shown). The system will then run and deliver a prepared substrate with deposited sample (not shown). The system will have a ready notification, by alarm, light, display or other notification. Following deposition, the cartridge 2602 may be removed either by opening the cartridge door 2604 causing the cartridge 2602 to be automatically released, by the press of a button (not shown) by the user to release the sample, or by a user manually pulling the cartridge 2602 out after opening the cartridge door 2604.
As shown in
Various embodiments of the present technology are further directed to automated control systems for sample processing. For example, some embodiments of the system 710 and/or computing environment 700 include modules for data acquisition, data maintenance, data retrieval for sample processing, such as information sharing of processing protocol and processing status via a communication component 750 and/or communication network 760. In certain embodiments, individual samples and/or multiple batch processing data, protocols and parameters can be uploaded to a remote server 770. Likewise, data relating to diagnostic features, real-time or adaptive capabilities for multiple batch processing and associated program processing parameters can be acquired, stored and later accessed.
The controller 712 (
The controller 712 can receive information (e.g., look-up tables, temperature set points, duty cycles, power settings, environmental information such as ambient temperatures and/or humidity, processing protocols, etc.) from the memory 716. An input device 722 can be a manual input device (e.g., a keyboard, a touch screen, user interface, or the like) or an automated input device (e.g., a computer 720, a data storage device 740, servers 770, network 760, etc.) that can provide information automatically upon request from the controller 712. The memory 716 can store different instructions for different processes. One stored sequence of program instructions can be used to mix the specimen container 200 and another sequence of program instructions can be used to spray the biological material onto the surface of a substrate 151. The controller 712 can include a programmable processor 713 that executes the sequence of program instructions in order to sequentially generate specimen-bearing substrates. Any number of sequences of program instructions can be executed to perform different stages of a protocol.
A power source 718 of the controller 712 can be one or more of batteries, fuel cells, or the like. The power source 718 can also deliver electrical energy to other components of the system 100. In other embodiments, the power source 718 can be an AC power supply. The controller 712 can also collect information from a plurality of sensors 719 provided by the system 100. For example, the system 100 can include pressure sensors, contact/touch sensors (e.g., for measuring contact pressure between the spray cartridge 120 and the specimen container 200), temperature sensors, positions sensors (e.g., optical sensor, laser sensor, etc.), light sensors, air pressure sensors, motion sensors, electromechanical sensors, chemical sensors, and the like.
Referring to
When engaged, the spray cartridge 120 (
In certain high-throughput embodiments, a series of spray cartridges 120 with loaded specimen containers 200 can used sequentially (or in tandem) to deposit biological material onto substrates 151. For example, in one embodiment, a carousel (not shown) can provide a series of spray cartridges 120 that can be rotated (e.g., via the drive mechanism 146) to position each spray cartridge 120, one or more at a time, above the substrate processing area 130.
In some embodiments, the substrate cartridges 150 and/or substrates 151 can receive additional processing steps in the loading station 134 or other processing station (not shown) in the system 100, such as heating (e.g., with a dehydration unit, a heating unit, a baking module, or other component capable of removing liquid from the slides), staining, hybridizing, washing, or for receiving coverslips or the like. In some embodiments, an air system can partially recirculate air to control the humidity in the internal environment 101. In other embodiments, drying, adding coverslips and/or other processing steps (e.g., staining, etc.) can occur manually and/or as post-deposition processing steps occurring outside of the internal environment 101 of the system 100. In some embodiments, the substrate 151 can remain housed in the substrate cartridge 150 during all or some additional processing steps. Once processing within the substrate cartridge 150 is complete, the substrate 151 bearing the spray-deposited specimen can be removed from the substrate cartridge by separating the lower and upper housing 153, 154 components via opening a hinged mechanism or disengaging one or more clips 155 securing the substrate cartridge 150.
Once aligned and positioned, for example, at the proper height above the substrate 151, the method 800 continues at block 810 by initiating compressed air to flow through and spray biological material from the specimen container 200 onto the surface of the substrate 151. Following spray deposition of the biological material, the method 800 can optionally include returning the spray cartridge 120 to a loading/unloading position separated from the substrate cartridge 150 (block 812). The method 800 can end, or alternatively, can include waiting for a new command from the controller 712 (block 814).
Other process flows and system commands are suitable for using the automated specimen deposition system 100 described herein with respect to
For clinical, diagnostic and research applications, high sample quality is desirable for deriving useful and accurate data from the samples. The system 100 and methods described herein facilitate generation of high-quality and reproducible specimen-bearing substrates. For example, the system is configured to both mix (or similar technique such as agitate, vortex, shake, etc.) the sample as well as count or determine cell concentration of each sample. Each collected biological sample may have a different quantity of cells thereby introducing variation between samples. In order to standardize the number of cells deposited onto a substrate, each sample can be quantified and the system 100 can adjust deposition parameters based on this information and desired criteria. For example, if a sample is assessed and determined to have 10,000 cells per mL of sample and the desired concentration of cells on the substrate is about 1,000 cells per square centimeter over a 1 square-centimeter area, then the system would deposit approximately 1/10 (or 100 microliters). In another example, a second biological sample is determined to have about 5,000 cells per mL of sample. In this example, and given the same desired concentration of cells on the substrate, they system 100 would deposit approximately ⅕ (or 200 microliters). As biological samples are expected to have variation in the quantity of cells present in the specimen container 200, it may be desirable to adjust parameters, such as spray volume, which will govern the quantity of cells deposited onto a substrate (e.g., per-spray volume, total-volume sprayed). Additional adjustments to spray volume may be made based on cell type(s) within the biological sample. For example, for samples containing large cells, the desired concentration of cells on the substrate maybe lowered.
In one embodiment, electrical impedance can be used for determining cell concentration within the sample. For example, as the cells are pumped through a chamber, the impedance changes which may be correlated to cell quantity in the tested sample. An alternative approach for determining cell concentration within the sample would include the use of a laser and sensor to detect changes in intensity due to the presence of shadows (e.g., as detected by an optical sensor). As intensity changes, voltage will vary, accurately assessing cell counts per volume. Each of these cell counting methods can be performed, for example, with the use of a motorized syringe pump to pull the sample through a chamber that would be controlled via the controller 712.
In various arrangements, the spray deposition process can be optimized for each biological sample. The spray deposition parameters (e.g., distance of spray nozzle from substrate, air pressure, air flow rate, nozzle design, per-spray volume, total volume, drying temperature, air drying time) can be a function of various sample properties, such as cell type, cell concentration, and transport or suspension liquid characteristics, such that:
distance, air pressure, air flow rate, nozzle design, per-spray volume, total volume, temperature drying, air drying]=f (cell type, concentration, liquid-type)
Biological sample preparation and deposition can vary based on cellular characteristics such as shape, size, and sensitivity (e.g., fragility). Examples of parameters that can be varied based on cell type/specimen type can include:
Biological sample preparation and deposition can vary based on cell concentration. As discussed above, the system can be provided with mechanisms and process steps for quantitatively assessing each sample prior to deposition. Examples of parameters that can be varied based on cell concentration can include:
Biological sample preparation and deposition can also vary based on the type/characteristics of the storage/transport liquid the biological sample is suspended within. For example, storage/transport liquids can vary in density and viscosity, which may alter the deposition of the biological material using the described spray system. Examples of parameters that can be varied based on liquid type can include:
The spray deposition parameters described above, as well as other parameters (e.g., liquid temperature, biological sample temperature, etc.) can be pre-programmed such that a user of the system can select and/or optimize the spray deposition program suitable for the type of cell or liquid in a particular biological sample. In some embodiments, the system 100 can screen the specimen-bearing substrates to determine if the spray deposition of the sample met the program criteria (e.g., sufficient cells were deposited, no overlapping cells etc.). Such screening methods may include screening the specimen-bearing slides by laser and/or by spectrographic techniques.
The instruments and systems of the present technology enable rapid, high throughput, and/or automated generation of specimen-bearing substrates. The benefits of these instruments, systems, and/or combination of components are not limited to any particular application. In some embodiments, any combination of components of a specimen deposition system may be utilized to achieve a desired function or process. In particular embodiments, specimen deposition systems provide a procedure and process for high quality specimen-bearing substrates, wherein a biological sample is deposited on substrates for further processing and or data collection, such as to identify targets or potential targets (e.g., cells, cells with potential nanoarchitectural abnormalities, potentially cancerous cells, etc.). Such embodiments allow for the generation of specimen-bearing substrates from which high resolution data can be acquired of targets in a suitable timeframe for research, clinical and/or diagnostic purposes.
A biological specimen can include one or more biological samples. Biological samples can be a tissue sample or samples (e.g., any collection of cells) removed from a subject. The tissue sample can be a collection of interconnected cells that perform a similar function within an organism. A biological sample can also be any solid or fluid sample obtained from, excreted by, or secreted by any living organism, including, without limitation, single-celled organisms, such as bacteria, yeast, protozoans, and amebae, multicellular organisms (such as plants or animals, including samples from a healthy or apparently healthy human subject or a human patient affected by a condition or disease to be diagnosed or investigated, such as cancer). In some embodiments, a biological sample is mountable on a microscope slide and includes, without limitation, a section of tissue, an organ, a tumor section, a smear, a frozen section, a cytology prep, or cell lines. An incisional biopsy, a core biopsy, an excisional biopsy, a needle aspiration biopsy, a core needle biopsy, a stereotactic biopsy, an open biopsy, or a surgical biopsy can be used to obtain the sample.
Buccal Cell Collection and Spray Deposition
The quality and reproducibility of spray deposition of biological samples on microscope slides, in accordance with aspects of the present technology was verified by performing experiments on collected Buccal cells. Buccal cells were harvested and collected in specimen vials containing different types of liquid (e.g., transport liquid). Cells were placed into the variable test liquids and then deposited on slides using the spray deposition methods described herein. Table 2 shows the type and concentration of the transport liquids used to collect and transport the buccal cells.
The proprietary solution, ThinPrep® Cytolyt®, did not yield suitable cell samples for PWS analysis. Specifically, cell samples prepared using spray deposition with ThinPrep® Cytolyt® exhibited isolated cells, however cell shape was distorted and/or cells had folding. As such, 25% ethanol in deionized water is a superior transfer liquid compared to Cytolyt when using spray deposition.
Other concentrations of ethanol in deionized water were tested as suitable transport solutions/preservative solutions for collecting and preserving buccal cell samples for imaging, PWS and/or other types of analysis. For example, 20% ethanol in deionized water (
Buccal cells collected and stored in 60% ethanol in deionized water (
Cell Deposition in Accordance with the Prior Art
There are inherent limitations with current liquid-based approaches for generating biological tissue prepared microscope slides. For example, microscope slides can be generated with too many cells, overlapping cells or with multiple layers of cells, which can make microscopy difficult or impossible. Further challenges include analyzing and diagnosing a patient from tissue samples when the cellular structures are distorted or deteriorated as a result of cell transfer to the slides. Cell smearing approaches also include the inherent challenges discussed above. Additionally, these techniques of placing the sampling collection device (e.g., spatula, brush, swab, etc.) on the glass slide results in capture of only the cells that are in contact with the slide and not a proportional representation on the slide of all the cells collected in a sample taken from the patient. In some cases, an inadequate number of cells are preserved on the slide, resulting in the need for re-screening. In using either technique for generating biological tissue prepared microscope slides, and even when the number of cells is adequate, the appearance of the resultant slide can be highly variable: the cells may be clumped, overlapping, and poorly preserved. Additionally, visibility of cellular features may be partially obscured by blood or drying artifacts.
The inherent draw backs to the conventional cell deposition techniques in the prior art result in large variability of sample quality as well as add variability and difficulty of sample preparation, collection and handling-time by clinicians and technicians. In contrast, aspects of the present technology provide high-quality prepared microscope slides with biological samples suitable for reproducible and high-quality preservation of cellular structures for accurate and/or high-resolution imaging and viewing for clinical, diagnostic and research purposes.
Aspects of the present disclosure relate to systems, apparatus and method for automated preparation of tissue samples on a substrate. Other aspects of the present technology relate to systems for sample processing and data acquisition, data maintenance, and data retrieval for sample processing. Furthermore, aspects of the present technology are directed to generation of high-quality, reproducible specimen-bearing substrates for diagnostic, clinical and other research applications. For example, structural aberrations, such as the cellular structural changes occurring during early neoplastic transformations (e.g., along a dysplasia-carcinoma sequence), typically occur relatively late in the process of carcinogenesis with the earlier stages generally silent from a pathological perspective and/or that detectable using conventional microscopy and/or with microscopic slide preparation as described above. From a clinical perspective (e.g., in cytological diagnosis), it is desirable to identify earlier stages of disease (e.g., carcinogenesis). At early stages, genetic/epigenetic changes may not yet have translated into microscopic consequences, although the fundamental nanoscale architecture of these cells may be perturbed during early neoplastic transformation. In particular the specimen-bearing substrates generated in accordance with aspects of the present technology are suitable for cytology techniques, such as PWS analysis.
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, an additional embodiment can include placing the specimen container(s) on a surface (e.g., platform) and aspirating contents from the specimen containers. The aspirated samples can be transferred (e.g., via automation) to a spray cartridge from which the biological material can be sprayed onto substrate(s). The various embodiments described herein may also be combined to provide further embodiments.
From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
This application is a continuation application of U.S. patent application Ser. No. 17/751,127 filed on May 23, 2022, which is a continuation of U.S. patent application No. Ser. No. 15/092,153 filed on Apr. 6, 2016, which claims priority to U.S. Provisional Patent Application Ser. No. 62/143,698, which was filed on Apr. 6, 2015, the entire contents of which are incorporated herein by reference and relied upon.
This invention was made with government support under R44 CA168185, R01 EB016983, R01 CA155284, and R01 CA156186 awarded by the National Institutes of Health. The government has certain rights in the invention.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4734718 | Iwagami et al. | Mar 1988 | A |
| 5059393 | Quenin et al. | Oct 1991 | A |
| 5256571 | Hurley et al. | Oct 1993 | A |
| 5425918 | Healey et al. | Jun 1995 | A |
| 5595346 | Haruch et al. | Jan 1997 | A |
| 5595707 | Copeland et al. | Jan 1997 | A |
| 5749551 | Torres et al. | May 1998 | A |
| 5952239 | Hayes et al. | Sep 1999 | A |
| 6918309 | Brock et al. | Jul 2005 | B2 |
| 7101511 | Toi et al. | Sep 2006 | B2 |
| 7468161 | Reinhardt et al. | Dec 2008 | B2 |
| 7470541 | Copeland | Dec 2008 | B2 |
| 7501283 | Hersch et al. | Mar 2009 | B2 |
| 7578206 | Brock et al. | Aug 2009 | B2 |
| 7652772 | Backman et al. | Jan 2010 | B2 |
| 7667832 | Backman et al. | Feb 2010 | B2 |
| 7800746 | Backman et al. | Sep 2010 | B2 |
| 7823469 | Takaya et al. | Nov 2010 | B2 |
| 7823535 | Hanafusa et al. | Nov 2010 | B2 |
| 8048373 | Reinhardt et al. | Nov 2011 | B2 |
| 8131348 | Backman et al. | Mar 2012 | B2 |
| 8735075 | Backman et al. | May 2014 | B2 |
| 9068955 | Voss et al. | Jun 2015 | B2 |
| 9091620 | Yi | Jul 2015 | B2 |
| 9261524 | Von Beichmann et al. | Feb 2016 | B2 |
| 9269138 | Zahniser et al. | Feb 2016 | B2 |
| 9778273 | Feingold et al. | Oct 2017 | B2 |
| 9778276 | Farr et al. | Oct 2017 | B2 |
| 9784652 | Zahniser et al. | Oct 2017 | B2 |
| 20050019223 | Platt et al. | Jan 2005 | A1 |
| 20050232823 | Brock et al. | Oct 2005 | A1 |
| 20060111807 | Gothait et al. | May 2006 | A1 |
| 20060155178 | Backman et al. | Jul 2006 | A1 |
| 20090124519 | Platt et al. | May 2009 | A1 |
| 20090269799 | Winkelman et al. | Oct 2009 | A1 |
| 20100092683 | Ermantraut et al. | Apr 2010 | A1 |
| 20110136162 | Sun et al. | Jun 2011 | A1 |
| 20120116568 | Murphy et al. | May 2012 | A1 |
| 20120320365 | Bartko et al. | Dec 2012 | A1 |
| 20130089642 | Lipson et al. | Apr 2013 | A1 |
| 20130295597 | DeWitte et al. | Nov 2013 | A1 |
| 20150300929 | Kirk et al. | Oct 2015 | A1 |
| 20150374450 | Mansfield | Dec 2015 | A1 |
| 20160076978 | Dave et al. | Mar 2016 | A1 |
| 20160236409 | Armani | Aug 2016 | A1 |
| 20160291045 | Czarnecki et al. | Oct 2016 | A1 |
| 20160370264 | Campbell | Dec 2016 | A1 |
| 20170082585 | DeWitte et al. | Mar 2017 | A1 |
| 20220276268 | Mendoza et al. | Sep 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 0381308 | Aug 1990 | EP |
| 1007937 | Oct 2003 | EP |
| 1453600 | Sep 2004 | EP |
| 1548448 | Jun 2005 | EP |
| 1717571 | Nov 2006 | EP |
| 1358012 | Aug 2008 | EP |
| 1939631 | Apr 2011 | EP |
| 2529237 | Dec 2012 | EP |
| 2541257 | Jan 2013 | EP |
| 1494808 | Jul 2013 | EP |
| 2872869 | May 2015 | EP |
| 2064557 | Sep 2015 | EP |
| 2917715 | Sep 2015 | EP |
| 2969177 | Jan 2016 | EP |
| 1663847 | Nov 2016 | EP |
| 3185016 | Jun 2017 | EP |
| S63168562 | Jul 1988 | JP |
| H06504115 | May 1994 | JP |
| 2005046665 | Feb 2005 | JP |
| 2007064901 | Mar 2007 | JP |
| 2012533745 | Dec 2012 | JP |
| 2013122462 | Jun 2013 | JP |
| 5249905 | Jul 2013 | JP |
| WO 0188179 | Nov 2001 | WO |
| WO 2007069586 | Jun 2007 | WO |
| WO 2008034914 | Mar 2008 | WO |
| WO 2010078177 | Jul 2010 | WO |
| WO 2014074456 | May 2014 | WO |
| WO 2014143981 | Sep 2014 | WO |
| WO 2015109270 | Jul 2015 | WO |
| WO 2016164431 | Oct 2016 | WO |
| Entry |
|---|
| Extended European Search Report dated Nov. 9, 2018 for European Application No. EP 16777179. |
| PCT/US16/26174 International Search Report dated Jul. 1, 2016. |
| Remel Ethanol 95%. Available at: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/IFU40132.pdf (Revised Feb. 9, 2010). |
| Webopedia: Cartridge definition, pp. 1-4. |
| Merriam Webster: definition of cartridge. |
| Your Dictionary: definition of vibrate. |
| Number | Date | Country | |
|---|---|---|---|
| 20240027481 A1 | Jan 2024 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62143698 | Apr 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17751127 | May 2022 | US |
| Child | 18164918 | US | |
| Parent | 15092153 | Apr 2016 | US |
| Child | 17751127 | US |
